Healthcare Sector Stocks
The Healthcare sector has a total of 1063 stocks, with a combined market cap of $8.32 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.20.
Market Cap
8.32T
Revenue
4.52T
Profits
207.08B
PE Ratio
40.20
Profit Margin
4.59%
Dividend Yield
0.44%
1063 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 841.35B | -1.56% | 845,888 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 577.03B | -0.72% | 2,272,085 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 371.86B | -1.02% | 1,352,552 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 318.03B | -0.28% | 796,573 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 300.73B | -0.75% | 3,733,983 | 65.01B |
| 6 | NVS | Novartis AG | 295.06B | -0.43% | 599,824 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 279.54B | 0.35% | 2,076,824 | 447.57B |
| 8 | AMGN | Amgen Inc. | 190.01B | -0.99% | 610,477 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 185.61B | -0.20% | 386,893 | 44.56B |
| 10 | ABT | Abbott Laboratories | 174.73B | -2.33% | 3,493,112 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 174.55B | -1.03% | 1,158,525 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 167.68B | 0.36% | 6,802,544 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 159.82B | -1.09% | 463,822 | 10.06B |
| 14 | PFE | Pfizer Inc. | 153.53B | -0.84% | 10,279,538 | 62.58B |
| 15 | DHR | Danaher Corporation | 134.63B | -1.42% | 1,034,099 | 24.57B |
| 16 | SYK | Stryker Corporation | 129.23B | -0.42% | 836,646 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.26B | -0.96% | 2,522,811 | 48.19B |
| 18 | GSK | GSK plc | 116.24B | 0.07% | 1,994,687 | 43.97B |
| 19 | SNY | Sanofi | 114.31B | -0.62% | 1,093,474 | 54.85B |
| 20 | MDT | Medtronic plc | 112.21B | -0.58% | 2,739,772 | 35.48B |
| 21 | HCA | HCA Healthcare, Inc. | 111.38B | -1.78% | 199,573 | 75.60B |
| 22 | VRTX | Vertex Pharmaceuticals Incorporated | 111.12B | -2.22% | 369,487 | 12.00B |
| 23 | MCK | McKesson Corporation | 106.13B | -0.80% | 199,146 | 397.96B |
| 24 | CVS | CVS Health Corporation | 100.90B | -0.14% | 1,444,593 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 90.89B | -0.20% | 4,359,180 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 76.74B | -2.61% | 234,933 | 14.34B |
| 27 | CI | The Cigna Group | 72.11B | -1.78% | 266,612 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 69.50B | -0.15% | 260,321 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.21B | -0.83% | 386,310 | 325.78B |
| 30 | MDLN | Medline Inc. | 60.32B | 0.50% | 1,524,886 | 28.43B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 56.89B | -2.17% | 1,618,398 | 28.48B |
| 32 | CAH | Cardinal Health, Inc. | 50.68B | -0.21% | 452,815 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.72B | -1.46% | 677,513 | 9.47B |
| 34 | ARGX | argenx SE | 49.22B | -0.08% | 165,571 | 4.24B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 45.16B | -3.00% | 183,226 | 4.30B |
| 36 | EW | Edwards Lifesciences Corporation | 44.85B | -1.71% | 1,558,350 | 6.07B |
| 37 | BDX | Becton, Dickinson and Company | 43.94B | -0.75% | 690,493 | 21.92B |
| 38 | HLN | Haleon plc | 43.73B | -1.70% | 2,058,638 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.32B | 1.67% | 287,704 | 3.71B |
| 40 | ALC | Alcon Inc. | 37.63B | 0.49% | 750,656 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 35.78B | -0.74% | 1,718,145 | 17.26B |
| 42 | ONC | BeOne Medicines AG | 34.46B | -0.84% | 41,075 | 5.34B |
| 43 | INSM | Insmed Incorporated | 33.28B | -3.38% | 485,211 | 606.42M |
| 44 | GEHC | GE HealthCare Technologies Inc. | 33.19B | -0.23% | 590,515 | 20.63B |
| 45 | RMD | ResMed Inc. | 33.19B | 0.37% | 132,711 | 5.40B |
| 46 | A | Agilent Technologies, Inc. | 32.62B | 0.04% | 307,919 | 7.07B |
| 47 | WAT | Waters Corporation | 31.24B | 0.25% | 214,371 | 3.17B |
| 48 | IQV | IQVIA Holdings Inc. | 28.00B | -1.30% | 402,519 | 16.31B |
| 49 | RPRX | Royalty Pharma plc | 27.63B | -0.85% | 731,126 | 2.38B |
| 50 | NTRA | Natera, Inc. | 27.39B | -4.81% | 988,987 | 2.31B |
| 51 | MTD | Mettler-Toledo International Inc. | 26.77B | -0.96% | 42,597 | 4.03B |
| 52 | PHG | Koninklijke Philips N.V. | 26.70B | 0.73% | 532,469 | 20.94B |
| 53 | BIIB | Biogen Inc. | 25.57B | -1.64% | 396,361 | 9.89B |
| 54 | UTHR | United Therapeutics Corporation | 24.91B | -1.11% | 127,094 | 3.18B |
| 55 | VEEV | Veeva Systems Inc. | 24.66B | -3.90% | 2,002,639 | 3.20B |
| 56 | DXCM | DexCom, Inc. | 24.61B | -2.66% | 555,610 | 4.66B |
| 57 | BNTX | BioNTech SE | 23.66B | 1.71% | 259,969 | 3.37B |
| 58 | HUM | Humana Inc. | 23.40B | -1.23% | 317,516 | 129.66B |
| 59 | LH | Labcorp Holdings Inc. | 21.85B | -2.97% | 284,516 | 13.95B |
| 60 | STE | STERIS plc | 21.81B | -0.61% | 121,733 | 5.83B |
| 61 | DGX | Quest Diagnostics Incorporated | 21.31B | -2.68% | 239,604 | 11.04B |
| 62 | MRNA | Moderna, Inc. | 20.72B | 1.86% | 3,718,050 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 20.14B | -1.19% | 1,295,213 | 13.31M |
| 64 | INCY | Incyte Corporation | 19.12B | -0.91% | 358,589 | 5.14B |
| 65 | RVMD | Revolution Medicines, Inc. | 18.89B | -0.95% | 726,380 | - |
| 66 | ILMN | Illumina, Inc. | 18.77B | -0.74% | 714,211 | 4.34B |
| 67 | WST | West Pharmaceutical Services, Inc. | 18.53B | -0.46% | 199,374 | 3.07B |
| 68 | CNC | Centene Corporation | 18.21B | -1.38% | 999,665 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 18.08B | 0.38% | 412,467 | 8.23B |
| 70 | GMAB | Genmab A/S | 17.32B | -0.21% | 776,144 | 3.72B |
| 71 | THC | Tenet Healthcare Corporation | 17.15B | -2.29% | 319,958 | 21.31B |
| 72 | VTRS | Viatris Inc. | 15.88B | 0.22% | 2,311,349 | 14.30B |
| 73 | SMMT | Summit Therapeutics Inc. | 15.22B | 1.66% | 754,997 | - |
| 74 | ASND | Ascendis Pharma A/S | 14.82B | -0.78% | 243,911 | 845.52M |
| 75 | BBIO | BridgeBio Pharma, Inc. | 14.42B | -1.54% | 291,993 | 502.08M |
| 76 | RGC | Regencell Bioscience Holdings Limited | 14.12B | 1.37% | 34,612 | - |
| 77 | SNN | Smith & Nephew plc | 14.07B | 1.06% | 250,559 | 6.16B |
| 78 | COO | The Cooper Companies, Inc. | 13.97B | 0.20% | 259,421 | 4.15B |
| 79 | MEDP | Medpace Holdings, Inc. | 13.95B | -2.59% | 72,427 | 2.53B |
| 80 | PODD | Insulet Corporation | 13.66B | -1.10% | 275,964 | 2.71B |
| 81 | NBIX | Neurocrine Biosciences, Inc. | 13.02B | -1.48% | 194,413 | 2.86B |
| 82 | PEN | Penumbra, Inc. | 12.95B | -0.08% | 192,728 | 1.40B |
| 83 | FMS | Fresenius Medical Care AG | 12.66B | 0.04% | 94,885 | 23.05B |
| 84 | ALGN | Align Technology, Inc. | 12.51B | 0.06% | 146,191 | 4.03B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 12.40B | -1.81% | 588,127 | 943.71M |
| 86 | GMED | Globus Medical, Inc. | 12.29B | -0.59% | 220,961 | 2.94B |
| 87 | JAZZ | Jazz Pharmaceuticals plc | 11.96B | -1.99% | 426,716 | 4.27B |
| 88 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.73B | -2.47% | 61,864 | 958.40M |
| 89 | ENSG | The Ensign Group, Inc. | 11.62B | -1.31% | 71,699 | 5.06B |
| 90 | ELAN | Elanco Animal Health Incorporated | 11.50B | -1.41% | 768,467 | 4.72B |
| 91 | SOLV | Solventum Corporation | 11.48B | 0.02% | 329,240 | 8.33B |
| 92 | EXEL | Exelixis, Inc. | 11.45B | -2.88% | 863,466 | 2.32B |
| 93 | UHS | Universal Health Services, Inc. | 11.21B | -2.21% | 119,941 | 17.36B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.03B | 0.94% | 657,361 | 3.85B |
| 95 | GH | Guardant Health, Inc. | 10.67B | -6.68% | 1,509,454 | 982.02M |
| 96 | EHC | Encompass Health Corporation | 10.66B | -1.06% | 158,076 | 5.94B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.51B | -2.94% | 473,077 | 3.22B |
| 98 | RVTY | Revvity, Inc. | 10.09B | -0.25% | 205,110 | 2.86B |
| 99 | DVA | DaVita Inc. | 10.02B | -0.41% | 121,539 | 13.64B |
| 100 | ABVX | ABIVAX Société Anonyme | 9.77B | -0.90% | 574,982 | 5.37M |
| 101 | MASI | Masimo Corporation | 9.31B | 0.01% | 166,260 | 1.53B |
| 102 | BTSG | BrightSpring Health Services, Inc. | 9.23B | -1.50% | 460,354 | 12.91B |
| 103 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.17B | -1.12% | 490,183 | 1.09B |
| 104 | AXSM | Axsome Therapeutics, Inc. | 9.11B | -0.50% | 166,544 | 638.50M |
| 105 | BAX | Baxter International Inc. | 8.91B | -0.20% | 1,310,013 | 11.24B |
| 106 | PRAX | Praxis Precision Medicines, Inc. | 8.83B | -1.05% | 125,624 | 7.46M |
| 107 | PCVX | Vaxcyte, Inc. | 8.71B | -1.88% | 327,073 | - |
| 108 | HSIC | Henry Schein, Inc. | 8.70B | 0.21% | 187,730 | 13.18B |
| 109 | TECH | Bio-Techne Corporation | 8.66B | -0.41% | 269,988 | 1.22B |
| 110 | CRL | Charles River Laboratories International, Inc. | 8.56B | -0.96% | 101,617 | 4.02B |
| 111 | QGEN | Qiagen N.V. | 8.47B | -0.15% | 387,515 | 2.09B |
| 112 | ATR | AptarGroup, Inc. | 8.42B | 0.48% | 80,090 | 3.78B |
| 113 | HALO | Halozyme Therapeutics, Inc. | 8.00B | 0.70% | 260,071 | 1.40B |
| 114 | NUVL | Nuvalent, Inc. | 7.99B | -2.81% | 161,360 | - |
| 115 | ICLR | ICON Public Limited Company | 7.99B | -1.94% | 211,919 | 8.10B |
| 116 | CYTK | Cytokinetics, Incorporated | 7.94B | -0.19% | 404,419 | 88.04M |
| 117 | TEM | Tempus AI, Inc. | 7.83B | -0.78% | 2,917,689 | 1.27B |
| 118 | MOH | Molina Healthcare, Inc. | 7.57B | 0.13% | 226,471 | 43.56B |
| 119 | KRYS | Krystal Biotech, Inc. | 7.56B | -0.56% | 56,419 | 389.13M |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.51B | 0.22% | 37,215 | 2.58B |
| 121 | IBRX | ImmunityBio, Inc. | 7.38B | -4.41% | 7,178,684 | 113.29M |
| 122 | KYMR | Kymera Therapeutics, Inc. | 6.92B | -3.03% | 123,341 | 39.21M |
| 123 | GKOS | Glaukos Corporation | 6.84B | -1.37% | 199,957 | 507.44M |
| 124 | RGEN | Repligen Corporation | 6.74B | -0.23% | 160,430 | 738.26M |
| 125 | ACLX | Arcellx, Inc. | 6.74B | 0.02% | 349,503 | 22.29M |
| 126 | HQY | HealthEquity, Inc. | 6.71B | -5.61% | 464,042 | 1.31B |
| 127 | BLTE | Belite Bio, Inc | 6.69B | -6.17% | 111,696 | - |
| 128 | GRFS | Grifols, S.A. | 6.47B | 1.63% | 282,447 | 8.83B |
| 129 | PTGX | Protagonist Therapeutics, Inc. | 6.38B | -3.93% | 139,303 | 46.02M |
| 130 | APGE | Apogee Therapeutics, Inc. | 6.35B | -0.54% | 172,834 | - |
| 131 | CNTA | Centessa Pharmaceuticals plc | 6.13B | -0.30% | 591,887 | 15.00M |
| 132 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.13% | 2,771,358 | - |
| 133 | BLCO | Bausch + Lomb Corporation | 5.85B | 0.12% | 101,111 | 5.10B |
| 134 | COGT | Cogent Biosciences, Inc. | 5.82B | -3.24% | 373,066 | - |
| 135 | BRKR | Bruker Corporation | 5.77B | -0.18% | 396,178 | 3.44B |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 5.73B | -4.09% | 109,341 | 521.31M |
| 137 | CGON | CG Oncology, Inc. | 5.72B | -1.17% | 476,026 | 4.04M |
| 138 | PTCT | PTC Therapeutics, Inc. | 5.69B | -2.92% | 127,898 | 1.73B |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.68B | -3.40% | 121,258 | 189.76M |
| 140 | CELC | Celcuity Inc. | 5.62B | -6.64% | 252,906 | - |
| 141 | SRRK | Scholar Rock Holding Corporation | 5.61B | -0.73% | 240,019 | - |
| 142 | ALKS | Alkermes plc | 5.61B | -3.41% | 781,194 | 1.48B |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 5.53B | -1.02% | 215,935 | 7.50M |
| 144 | PACS | PACS Group, Inc. | 5.38B | -4.84% | 183,547 | 5.29B |
| 145 | CHE | Chemed Corporation | 5.33B | -0.94% | 42,172 | 2.53B |
| 146 | AVTR | Avantor, Inc. | 5.32B | -0.69% | 1,658,047 | 6.55B |
| 147 | TFX | Teleflex Incorporated | 5.25B | -1.26% | 168,655 | 1.99B |
| 148 | LNTH | Lantheus Holdings, Inc. | 5.22B | -1.30% | 94,785 | 1.54B |
| 149 | ERAS | Erasca, Inc. | 5.21B | -3.51% | 1,028,550 | - |
| 150 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.14% | 3,547,940 | 1.00B |
| 151 | CAI | Caris Life Sciences, Inc. | 5.14B | -5.26% | 1,023,630 | 812.03M |
| 152 | IMVT | Immunovant, Inc. | 5.05B | -3.20% | 308,408 | - |
| 153 | TGTX | TG Therapeutics, Inc. | 5.03B | -1.69% | 399,245 | 616.29M |
| 154 | CRSP | CRISPR Therapeutics AG | 4.83B | -2.75% | 427,702 | 3.51M |
| 155 | DNTH | Dianthus Therapeutics, Inc. | 4.72B | -2.80% | 185,566 | 2.04M |
| 156 | OPCH | Option Care Health, Inc. | 4.57B | -0.78% | 537,339 | 5.65B |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 893,719 | 634.21M |
| 158 | HIMS | Hims & Hers Health, Inc. | 4.46B | -0.91% | 9,432,753 | 2.35B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.43B | -1.40% | 167,575 | 761.41M |
| 160 | SHC | Sotera Health Company | 4.37B | 0.46% | 570,864 | 1.16B |
| 161 | NVST | Envista Holdings Corporation | 4.35B | -0.49% | 412,553 | 2.72B |
| 162 | OSCR | Oscar Health, Inc. | 4.29B | -0.83% | 1,944,177 | 11.70B |
| 163 | RDNT | RadNet, Inc. | 4.28B | -1.73% | 126,014 | 2.04B |
| 164 | ALHC | Alignment Healthcare, Inc. | 4.20B | -3.93% | 769,678 | 3.95B |
| 165 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.11B | -0.86% | 291,373 | 7.70M |
| 166 | MMED | Minimed Group, Inc. | 4.09B | 5.43% | 314,689 | 2.89B |
| 167 | WAY | Waystar Holding Corp. | 4.08B | -2.52% | 638,762 | 1.10B |
| 168 | SYRE | Spyre Therapeutics, Inc. | 4.05B | -0.50% | 183,010 | - |
| 169 | MMSI | Merit Medical Systems, Inc. | 4.04B | -0.96% | 150,646 | 1.52B |
| 170 | LGND | Ligand Pharmaceuticals Incorporated | 4.03B | -1.62% | 185,878 | 268.09M |
| 171 | NAMS | NewAmsterdam Pharma Company N.V. | 4.01B | -0.66% | 200,971 | 22.50M |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 3.99B | -2.19% | 481,571 | 3.02B |
| 173 | VKTX | Viking Therapeutics, Inc. | 3.95B | -2.43% | 851,187 | - |
| 174 | DOCS | Doximity, Inc. | 3.92B | 0.24% | 1,427,064 | 637.78M |
| 175 | TMDX | TransMedics Group, Inc. | 3.84B | 2.56% | 377,680 | 605.49M |
| 176 | GPCR | Structure Therapeutics Inc. | 3.78B | -3.30% | 515,502 | - |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.74B | -2.09% | 54,015 | 747.14M |
| 178 | STVN | Stevanato Group S.p.A. | 3.70B | -1.53% | 151,707 | 1.39B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 3.66B | -4.96% | 334,872 | 1.07B |
| 180 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.60B | -0.53% | 165,776 | 677.56M |
| 181 | BLLN | BillionToOne, Inc. | 3.57B | -5.96% | 181,365 | 305.11M |
| 182 | TLX | Telix Pharmaceuticals Limited | 3.51B | 6.17% | 243,844 | 803.79M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.48B | -3.13% | 201,604 | - |
| 184 | LQDA | Liquidia Corporation | 3.43B | -3.40% | 611,420 | 158.32M |
| 185 | LIVN | LivaNova PLC | 3.41B | -1.53% | 212,582 | 1.39B |
| 186 | LEGN | Legend Biotech Corporation | 3.33B | -0.99% | 699,117 | 1.03B |
| 187 | BKD | Brookdale Senior Living Inc. | 3.23B | -1.31% | 680,853 | 3.05B |
| 188 | ICUI | ICU Medical, Inc. | 3.19B | 1.44% | 50,752 | 2.23B |
| 189 | VERA | Vera Therapeutics, Inc. | 3.11B | 6.43% | 728,774 | - |
| 190 | DYN | Dyne Therapeutics, Inc. | 3.10B | -3.05% | 524,242 | - |
| 191 | TARS | Tarsus Pharmaceuticals, Inc. | 3.09B | 0.30% | 120,118 | 451.36M |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | -2.34% | 384,353 | 588.99M |
| 193 | DNLI | Denali Therapeutics Inc. | 3.02B | -1.30% | 338,251 | - |
| 194 | ORKA | Oruka Therapeutics, Inc. | 2.97B | -5.90% | 341,230 | - |
| 195 | ARQT | Arcutis Biotherapeutics, Inc. | 2.94B | -3.42% | 283,251 | 376.07M |
| 196 | ALMS | Alumis Inc. | 2.92B | 0.04% | 333,454 | 24.05M |
| 197 | TXG | 10x Genomics, Inc. | 2.91B | -0.83% | 559,652 | 642.82M |
| 198 | TWST | Twist Bioscience Corporation | 2.91B | -2.78% | 247,654 | 391.56M |
| 199 | SUPN | Supernus Pharmaceuticals, Inc. | 2.91B | -1.96% | 118,651 | 718.95M |
| 200 | ITGR | Integer Holdings Corporation | 2.90B | -1.96% | 59,095 | 1.85B |
| 201 | TNGX | Tango Therapeutics, Inc. | 2.83B | -4.20% | 919,778 | 62.38M |
| 202 | RCUS | Arcus Biosciences, Inc. | 2.83B | -3.14% | 156,730 | 247.00M |
| 203 | PRVA | Privia Health Group, Inc. | 2.82B | -1.10% | 190,545 | 2.12B |
| 204 | HNGE | Hinge Health, Inc. | 2.79B | -1.39% | 389,637 | 587.86M |
| 205 | CON | Concentra Group Holdings Parent, Inc. | 2.78B | -2.48% | 169,687 | 2.16B |
| 206 | TVTX | Travere Therapeutics, Inc. | 2.74B | -5.50% | 750,306 | 490.73M |
| 207 | ELVN | Enliven Therapeutics, Inc. | 2.72B | -0.29% | 446,643 | - |
| 208 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.01% | 1,207,565 | 190.41M |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 2.67B | -1.74% | 289,944 | 218.71M |
| 210 | PBH | Prestige Consumer Healthcare Inc. | 2.67B | -0.49% | 65,364 | 1.10B |
| 211 | KOD | Kodiak Sciences Inc. | 2.67B | 2.10% | 347,224 | - |
| 212 | NHC | National HealthCare Corporation | 2.66B | -3.60% | 61,127 | 1.52B |
| 213 | HAE | Haemonetics Corporation | 2.66B | -2.16% | 121,290 | 1.32B |
| 214 | BEAM | Beam Therapeutics Inc. | 2.63B | 0.46% | 669,606 | 139.74M |
| 215 | RLAY | Relay Therapeutics, Inc. | 2.61B | -2.47% | 1,342,668 | 15.36M |
| 216 | LMAT | LeMaitre Vascular, Inc. | 2.59B | 0.75% | 56,479 | 249.60M |
| 217 | WRBY | Warby Parker Inc. | 2.56B | -0.33% | 469,609 | 871.91M |
| 218 | CLDX | Celldex Therapeutics, Inc. | 2.55B | -3.15% | 224,803 | 1.55M |
| 219 | IRON | Disc Medicine, Inc. | 2.52B | -1.74% | 62,961 | - |
| 220 | LFST | LifeStance Health Group, Inc. | 2.48B | -1.77% | 210,334 | 1.42B |
| 221 | HCM | HUTCHMED (China) Limited | 2.48B | -0.07% | 11,452 | 548.51M |
| 222 | GRDN | Guardian Pharmacy Services, Inc. | 2.48B | -3.62% | 99,578 | 1.45B |
| 223 | MANE | Veradermics, Incorporated | 2.48B | 10.70% | 202,330 | - |
| 224 | VCYT | Veracyte, Inc. | 2.47B | -0.83% | 292,840 | 517.15M |
| 225 | IMNM | Immunome, Inc. | 2.46B | -3.12% | 584,226 | 6.94M |
| 226 | ACHC | Acadia Healthcare Company, Inc. | 2.41B | -3.68% | 804,583 | 3.31B |
| 227 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.40B | -3.19% | 1,665,068 | 874.84M |
| 228 | PAHC | Phibro Animal Health Corporation | 2.35B | -1.74% | 41,058 | 1.46B |
| 229 | XRAY | DENTSPLY SIRONA Inc. | 2.35B | -0.59% | 689,507 | 3.68B |
| 230 | ADMA | ADMA Biologics, Inc. | 2.32B | -2.11% | 1,181,844 | 510.17M |
| 231 | ZLAB | Zai Lab Limited | 2.32B | -0.92% | 154,437 | 460.16M |
| 232 | AAPG | Ascentage Pharma Group International | 2.31B | -1.88% | 147 | 82.08M |
| 233 | HTFL | HeartFlow, Inc. | 2.27B | -2.10% | 245,069 | 176.03M |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | -3.14% | 397,060 | 673.00M |
| 235 | SRPT | Sarepta Therapeutics, Inc. | 2.23B | -4.41% | 522,436 | 2.20B |
| 236 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.07% | 455,647 | 158.18M |
| 237 | NKTR | Nektar Therapeutics | 2.21B | -1.09% | 181,589 | 55.23M |
| 238 | OGN | Organon & Co. | 2.17B | 20.84% | 26,554,209 | 6.22B |
| 239 | MLYS | Mineralys Therapeutics, Inc. | 2.17B | -3.09% | 358,566 | - |
| 240 | DFTX | Definium Therapeutics, Inc. | 2.14B | 0.33% | 776,094 | - |
| 241 | SNDX | Syndax Pharmaceuticals, Inc. | 2.14B | -2.06% | 336,241 | 172.35M |
| 242 | AUPH | Aurinia Pharmaceuticals Inc. | 2.08B | -1.79% | 366,897 | 283.06M |
| 243 | NEOG | Neogen Corporation | 2.08B | -4.63% | 1,642,263 | 870.56M |
| 244 | BHC | Bausch Health Companies Inc. | 2.07B | 3.71% | 908,623 | 10.27B |
| 245 | STOK | Stoke Therapeutics, Inc. | 2.04B | -2.08% | 105,157 | 184.42M |
| 246 | SEM | Select Medical Holdings Corporation | 2.03B | 0.12% | 435,308 | 5.45B |
| 247 | ANAB | AnaptysBio, Inc. | 1.94B | -1.36% | 94,552 | 234.60M |
| 248 | ZYME | Zymeworks Inc. | 1.94B | -3.69% | 204,770 | 105.97M |
| 249 | MESO | Mesoblast Limited | 1.93B | 2.37% | 104,337 | 65.38M |
| 250 | ADPT | Adaptive Biotechnologies Corporation | 1.93B | -6.27% | 1,441,534 | 276.98M |
| 251 | AHG | Akso Health Group | 1.93B | -0.44% | 153,153 | 14.84M |
| 252 | AGIO | Agios Pharmaceuticals, Inc. | 1.91B | -0.76% | 197,458 | 54.03M |
| 253 | OCUL | Ocular Therapeutix, Inc. | 1.90B | -6.24% | 1,304,400 | 51.95M |
| 254 | TYRA | Tyra Biosciences, Inc. | 1.89B | -4.33% | 278,667 | - |
| 255 | GLPG | Galapagos NV | 1.88B | 0.14% | 69,038 | 1.31B |
| 256 | GRAL | GRAIL, Inc. | 1.88B | -3.87% | 447,870 | 147.17M |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.84B | -3.64% | 285,078 | -665.00K |
| 258 | PVLA | Palvella Therapeutics, Inc. | 1.80B | -3.24% | 74,371 | - |
| 259 | AORT | Artivion, Inc. | 1.80B | 1.70% | 111,314 | 441.33M |
| 260 | CAPR | Capricor Therapeutics, Inc. | 1.79B | -1.77% | 348,912 | 11.13M |
| 261 | ESTA | Establishment Labs Holdings Inc. | 1.78B | -1.91% | 84,402 | 211.08M |
| 262 | INVA | Innoviva, Inc. | 1.78B | -0.79% | 214,795 | 411.33M |
| 263 | MD | Pediatrix Medical Group, Inc. | 1.73B | 0.05% | 128,541 | 1.91B |
| 264 | WGS | GeneDx Holdings Corp. | 1.73B | -1.75% | 193,281 | 427.54M |
| 265 | RXRX | Recursion Pharmaceuticals, Inc. | 1.72B | -1.66% | 4,243,080 | 74.68M |
| 266 | PHVS | Pharvaris N.V. | 1.71B | -3.14% | 46,578 | - |
| 267 | VCEL | Vericel Corporation | 1.70B | -0.60% | 93,531 | 276.26M |
| 268 | AXGN | Axogen, Inc. | 1.69B | -1.61% | 184,932 | 225.21M |
| 269 | ATEC | Alphatec Holdings, Inc. | 1.68B | 0.09% | 378,145 | 764.16M |
| 270 | HRMY | Harmony Biosciences Holdings, Inc. | 1.68B | -0.69% | 169,658 | 868.45M |
| 271 | NRIX | Nurix Therapeutics, Inc. | 1.67B | -0.55% | 549,820 | 71.78M |
| 272 | SGRY | Surgery Partners, Inc. | 1.66B | 0.15% | 275,575 | 3.31B |
| 273 | TRVI | Trevi Therapeutics, Inc. | 1.66B | -2.78% | 278,039 | - |
| 274 | ADUS | Addus HomeCare Corporation | 1.65B | -1.68% | 55,910 | 1.42B |
| 275 | AHCO | AdaptHealth Corp. | 1.65B | -0.45% | 178,332 | 3.24B |
| 276 | ANIP | ANI Pharmaceuticals, Inc. | 1.65B | -1.43% | 60,960 | 883.37M |
| 277 | SION | Sionna Therapeutics, Inc. | 1.65B | -5.84% | 95,137 | - |
| 278 | RAPP | Rapport Therapeutics, Inc. | 1.62B | -0.70% | 65,058 | - |
| 279 | IOVA | Iovance Biotherapeutics, Inc. | 1.62B | -1.75% | 32,354,346 | 263.50M |
| 280 | OCS | Oculis Holding AG | 1.61B | 0.31% | 31,595 | 1.51M |
| 281 | IMCR | Immunocore Holdings plc | 1.58B | -2.26% | 89,253 | 400.02M |
| 282 | NTLA | Intellia Therapeutics, Inc. | 1.57B | -3.72% | 732,836 | 67.67M |
| 283 | UFPT | UFP Technologies, Inc. | 1.56B | -0.42% | 78,781 | 602.80M |
| 284 | DMRA | Damora Therapeutics, Inc. | 1.56B | -3.11% | 150,783 | - |
| 285 | OMCL | Omnicell, Inc. | 1.55B | -3.98% | 120,997 | 1.18B |
| 286 | INSP | Inspire Medical Systems, Inc. | 1.55B | -5.34% | 541,239 | 911.98M |
| 287 | NUVB | Nuvation Bio Inc. | 1.53B | -3.46% | 1,383,899 | 62.90M |
| 288 | VRDN | Viridian Therapeutics, Inc. | 1.52B | -3.45% | 680,299 | 70.85M |
| 289 | VIR | Vir Biotechnology, Inc. | 1.52B | -3.56% | 507,573 | 68.56M |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.51B | -0.95% | 273,127 | 336.39M |
| 291 | PRGO | Perrigo Company plc | 1.50B | 2.83% | 527,236 | 4.25B |
| 292 | ARDX | Ardelyx, Inc. | 1.50B | -0.24% | 2,076,233 | 407.32M |
| 293 | GENB | Generate Biomedicines, Inc. | 1.48B | 1.04% | 228,076 | 31.89M |
| 294 | MBX | MBX Biosciences, Inc. | 1.48B | -5.51% | 114,990 | - |
| 295 | NBTX | Nanobiotix S.A. | 1.46B | 0.23% | 35,127 | 38.27M |
| 296 | PGEN | Precigen, Inc. | 1.45B | -3.98% | 1,313,774 | 9.68M |
| 297 | ATRC | AtriCure, Inc. | 1.42B | 0.11% | 174,634 | 534.53M |
| 298 | GLUE | Monte Rosa Therapeutics, Inc. | 1.41B | -2.27% | 286,099 | 123.67M |
| 299 | OLMA | Olema Pharmaceuticals, Inc. | 1.41B | -2.76% | 548,850 | - |
| 300 | SVRA | Savara Inc. | 1.40B | -5.96% | 531,213 | - |
| 301 | IMTX | Immatics N.V. | 1.40B | -2.35% | 73,325 | 56.67M |
| 302 | BCAX | Bicara Therapeutics Inc. | 1.39B | -3.28% | 144,038 | - |
| 303 | ENOV | Enovis Corporation | 1.38B | 0.02% | 87,462 | 2.25B |
| 304 | AVAH | Aveanna Healthcare Holdings Inc. | 1.37B | -4.69% | 249,498 | 2.43B |
| 305 | BHVN | Biohaven Ltd. | 1.36B | -3.41% | 366,269 | - |
| 306 | ASTH | Astrana Health, Inc. | 1.36B | -2.44% | 116,641 | 3.18B |
| 307 | HROW | Harrow, Inc. | 1.36B | -1.96% | 140,630 | 272.30M |
| 308 | HCSG | Healthcare Services Group, Inc. | 1.36B | -0.10% | 175,501 | 1.84B |
| 309 | NVAX | Novavax, Inc. | 1.35B | -3.28% | 1,204,021 | 1.12B |
| 310 | WVE | Wave Life Sciences Ltd. | 1.34B | -0.28% | 668,141 | 42.73M |
| 311 | ARDT | Ardent Health, Inc. | 1.34B | -1.68% | 75,046 | 6.32B |
| 312 | ATAI | AtaiBeckley Inc. | 1.33B | -1.08% | 1,148,946 | 4.09M |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.32B | -5.09% | 345,929 | 2.50M |
| 314 | TNDM | Tandem Diabetes Care, Inc. | 1.30B | -3.51% | 348,289 | 1.01B |
| 315 | PRCT | PROCEPT BioRobotics Corporation | 1.30B | -1.29% | 282,957 | 308.05M |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.29B | -7.16% | 441,663 | - |
| 317 | STAA | STAAR Surgical Company | 1.29B | 3.13% | 922,021 | 239.44M |
| 318 | PGNY | Progyny, Inc. | 1.26B | -2.36% | 314,580 | 1.29B |
| 319 | TSHA | Taysha Gene Therapies, Inc. | 1.26B | -4.97% | 789,430 | 9.77M |
| 320 | CRVS | Corvus Pharmaceuticals, Inc. | 1.26B | -4.21% | 201,611 | - |
| 321 | PLSE | Pulse Biosciences, Inc. | 1.22B | -6.49% | 75,427 | 350.00K |
| 322 | NVCR | NovoCure Limited | 1.21B | -3.45% | 217,356 | 655.35M |
| 323 | ZBIO | Zenas BioPharma, Inc. | 1.21B | -4.61% | 113,980 | 10.00M |
| 324 | IRMD | IRADIMED CORPORATION | 1.20B | -1.37% | 77,490 | 83.81M |
| 325 | PHAR | Pharming Group N.V. | 1.20B | 1.12% | 2,802 | 376.13M |
| 326 | MPLT | MapLight Therapeutics, Inc. | 1.19B | -7.87% | 197,765 | - |
| 327 | NNNN | Anbio Biotechnology | 1.17B | -0.74% | 1,239 | 8.65M |
| 328 | EYPT | EyePoint, Inc. | 1.17B | -1.62% | 322,486 | 31.37M |
| 329 | DBVT | DBV Technologies S.A. | 1.17B | -3.32% | 106,256 | 5.64M |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.15B | -1.22% | 53,414 | 773.34M |
| 331 | AVBP | ArriVent BioPharma, Inc. | 1.14B | -5.19% | 123,510 | - |
| 332 | ALVO | Alvotech | 1.14B | 0.83% | 73,400 | 588.90M |
| 333 | COLL | Collegium Pharmaceutical, Inc. | 1.11B | -0.57% | 131,778 | 780.57M |
| 334 | INNV | InnovAge Holding Corp. | 1.11B | -3.77% | 86,804 | 915.37M |
| 335 | CNMD | CONMED Corporation | 1.10B | -1.52% | 52,776 | 1.37B |
| 336 | INBX | Inhibrx Biosciences, Inc. | 1.09B | -1.11% | 119,912 | 1.30M |
| 337 | KMTS | Kestra Medical Technologies, Ltd. | 1.08B | -3.79% | 49,494 | 83.72M |
| 338 | GERN | Geron Corporation | 1.07B | -4.83% | 6,069,959 | 183.88M |
| 339 | ABCL | AbCellera Biologics Inc. | 1.06B | 1.74% | 1,618,644 | 75.13M |
| 340 | PNTG | The Pennant Group, Inc. | 1.06B | -4.20% | 43,146 | 947.71M |
| 341 | SEPN | Septerna, Inc. | 1.05B | -5.40% | 248,572 | 45.95M |
| 342 | BFLY | Butterfly Network, Inc. | 1.05B | -0.36% | 1,152,542 | 97.61M |
| 343 | AZTA | Azenta, Inc. | 1.03B | -1.72% | 221,999 | 595.03M |
| 344 | URGN | UroGen Pharma Ltd. | 1.02B | 2.17% | 374,132 | 109.79M |
| 345 | ORIC | ORIC Pharmaceuticals, Inc. | 1.02B | -2.12% | 741,200 | - |
| 346 | NEO | NeoGenomics, Inc. | 1.01B | -2.39% | 907,776 | 727.33M |
| 347 | PHAT | Phathom Pharmaceuticals, Inc. | 1.01B | 0.24% | 563,459 | 175.11M |
| 348 | CLOV | Clover Health Investments, Corp. | 1.00B | 0.26% | 2,344,848 | 1.92B |
| 349 | XERS | Xeris Biopharma Holdings, Inc. | 1.00B | -3.33% | 363,837 | 291.85M |
| 350 | KALV | KalVista Pharmaceuticals, Inc. | 980.40M | -4.06% | 222,456 | 73.62M |
| 351 | IVA | Inventiva S.A. | 979.97M | -4.55% | 566,553 | 9.31M |
| 352 | EVMN | Evommune, Inc. | 978.98M | -5.13% | 78,612 | 13.00M |
| 353 | CRON | Cronos Group Inc. | 970.60M | -0.39% | 204,413 | 146.59M |
| 354 | GHRS | GH Research PLC | 967.04M | 2.10% | 50,531 | - |
| 355 | BLFS | BioLife Solutions, Inc. | 959.72M | -2.98% | 117,375 | 96.21M |
| 356 | PCRX | Pacira BioSciences, Inc. | 956.98M | -0.78% | 87,816 | 726.41M |
| 357 | CTMX | CytomX Therapeutics, Inc. | 954.42M | 4.13% | 798,516 | 76.20M |
| 358 | QDEL | QuidelOrtho Corporation | 951.10M | -1.27% | 779,805 | 2.73B |
| 359 | QURE | uniQure N.V. | 941.69M | -7.61% | 1,800,261 | 16.10M |
| 360 | EVO | Evotec SE | 938.89M | -0.38% | 19,678 | 925.65M |
| 361 | AMPH | Amphastar Pharmaceuticals, Inc. | 936.21M | -1.13% | 75,583 | 719.89M |
| 362 | CMPX | Compass Therapeutics, Inc. | 931.05M | -5.14% | 1,584,362 | 850.00K |
| 363 | ANNX | Annexon, Inc. | 925.94M | -6.03% | 876,846 | - |
| 364 | TDOC | Teladoc Health, Inc. | 920.53M | -1.71% | 1,223,272 | 2.53B |
| 365 | SSII | SS Innovations International, Inc. | 899.73M | -0.44% | 14,208 | 42.48M |
| 366 | JANX | Janux Therapeutics, Inc. | 899.09M | 1.72% | 316,310 | 10.00M |
| 367 | AKTS | Aktis Oncology, Inc. | 897.41M | -8.12% | 117,288 | 6.50M |
| 368 | XNCR | Xencor, Inc. | 896.56M | -2.43% | 109,238 | 125.58M |
| 369 | LMRI | Lumexa Imaging Holdings, Inc. | 883.25M | -1.18% | 117,093 | 1.02B |
| 370 | SLS | SELLAS Life Sciences Group, Inc. | 879.95M | -2.97% | 1,862,039 | - |
| 371 | CGEM | Cullinan Therapeutics, Inc. | 878.23M | -4.60% | 127,942 | - |
| 372 | OPK | OPKO Health, Inc. | 872.93M | -1.71% | 456,745 | 606.88M |
| 373 | JBIO | Jade Biosciences, Inc. | 870.93M | -3.13% | 360,554 | - |
| 374 | INMD | InMode Ltd. | 870.55M | 0.37% | 241,513 | 370.50M |
| 375 | TALK | Talkspace, Inc. | 865.45M | 0.29% | 419,559 | 228.87M |
| 376 | FTRE | Fortrea Holdings Inc. | 846.64M | -3.46% | 171,803 | 2.72B |
| 377 | CERT | Certara, Inc. | 844.82M | 1.85% | 1,197,168 | 418.84M |
| 378 | DRUG | Bright Minds Biosciences Inc. | 841.67M | -2.92% | 44,733 | - |
| 379 | CDNA | CareDx, Inc. | 836.88M | -2.10% | 192,401 | 379.81M |
| 380 | TBPH | Theravance Biopharma, Inc. | 835.73M | -1.93% | 101,829 | 107.46M |
| 381 | SDGR | Schrödinger, Inc. | 832.01M | -1.74% | 637,863 | 255.87M |
| 382 | VOR | Vor Biopharma Inc. | 830.66M | -1.73% | 190,843 | - |
| 383 | OMER | Omeros Corporation | 829.40M | -3.27% | 403,487 | - |
| 384 | SANA | Sana Biotechnology, Inc. | 821.95M | -1.28% | 758,903 | - |
| 385 | ABUS | Arbutus Biopharma Corporation | 821.01M | -2.33% | 1,895,081 | 14.08M |
| 386 | SPRY | ARS Pharmaceuticals, Inc. | 807.29M | -1.69% | 206,124 | 84.28M |
| 387 | MNKD | MannKind Corporation | 801.06M | 1.56% | 1,248,006 | 348.97M |
| 388 | MRVI | Maravai LifeSciences Holdings, Inc. | 791.77M | -0.96% | 406,402 | 185.74M |
| 389 | SLDB | Solid Biosciences Inc. | 781.23M | -1.98% | 318,083 | - |
| 390 | IART | Integra LifeSciences Holdings Corporation | 773.53M | 0.97% | 107,098 | 1.64B |
| 391 | RLMD | Relmada Therapeutics, Inc. | 764.64M | -4.20% | 732,034 | - |
| 392 | TLRY | Tilray Brands, Inc. | 763.03M | -2.31% | 977,228 | 858.28M |
| 393 | KURA | Kura Oncology, Inc. | 758.75M | -2.94% | 346,867 | 67.48M |
| 394 | GDRX | GoodRx Holdings, Inc. | 751.95M | 1.62% | 1,462,033 | 796.85M |
| 395 | BVS | Bioventus Inc. | 748.39M | -1.10% | 104,913 | 568.09M |
| 396 | BIOA | BioAge Labs, Inc. | 740.25M | -6.24% | 90,290 | 9.00M |
| 397 | DSGN | Design Therapeutics, Inc. | 738.83M | -4.08% | 72,807 | - |
| 398 | CMPS | COMPASS Pathways plc | 728.42M | 1.25% | 469,677 | - |
| 399 | LXRX | Lexicon Pharmaceuticals, Inc. | 726.61M | -2.56% | 696,651 | 49.80M |
| 400 | MGTX | MeiraGTx Holdings plc | 726.50M | -4.50% | 193,752 | 81.39M |
| 401 | ETON | Eton Pharmaceuticals, Inc. | 721.13M | -2.47% | 84,076 | 79.95M |
| 402 | NUTX | Nutex Health Inc. | 717.25M | -2.62% | 64,436 | 875.26M |
| 403 | TENX | Tenax Therapeutics, Inc. | 715.27M | -4.95% | 104,972 | - |
| 404 | EHAB | Enhabit, Inc. | 708.86M | -0.11% | 230,972 | 1.06B |
| 405 | ANRO | Alto Neuroscience, Inc. | 700.57M | -2.10% | 50,190 | - |
| 406 | SGP | SpyGlass Pharma, Inc. | 696.94M | -1.74% | 62,993 | - |
| 407 | ARVN | Arvinas, Inc. | 695.90M | -2.60% | 133,681 | 262.60M |
| 408 | AMN | AMN Healthcare Services, Inc. | 695.43M | -2.70% | 117,730 | 2.73B |
| 409 | CBLL | CeriBell, Inc. | 683.94M | -2.15% | 46,486 | 89.06M |
| 410 | ALLO | Allogene Therapeutics, Inc. | 667.93M | -5.85% | 2,120,737 | 22.00K |
| 411 | OMDA | Omada Health, Inc. | 665.27M | -5.76% | 235,827 | 260.21M |
| 412 | GYRE | Gyre Therapeutics, Inc. | 661.57M | 0.07% | 21,379 | 116.59M |
| 413 | CSTL | Castle Biosciences, Inc. | 661.22M | -5.08% | 52,462 | 344.23M |
| 414 | AVNS | Avanos Medical, Inc. | 660.88M | 0.85% | 74,827 | 701.20M |
| 415 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 657.07M | -7.28% | 136,913 | - |
| 416 | FBRX | Forte Biosciences, Inc. | 634.56M | -0.27% | 200,727 | - |
| 417 | DRTS | Alpha Tau Medical Ltd. | 633.67M | -2.04% | 74,960 | - |
| 418 | LBRX | LB Pharmaceuticals Inc | 627.42M | -5.67% | 253,377 | - |
| 419 | PSNL | Personalis, Inc. | 623.88M | -2.13% | 538,143 | 69.65M |
| 420 | CBIO | Crescent Biopharma, Inc. | 619.77M | -2.30% | 60,585 | 10.84M |
| 421 | OCGN | Ocugen, Inc. | 606.53M | -4.01% | 3,469,350 | 4.41M |
| 422 | HSTM | HealthStream, Inc. | 586.83M | 0.40% | 111,475 | 304.06M |
| 423 | PRME | Prime Medicine, Inc. | 586.13M | -5.70% | 793,380 | 4.63M |
| 424 | CRMD | CorMedix Inc. | 576.67M | -0.88% | 273,488 | 311.71M |
| 425 | TECX | Tectonic Therapeutic, Inc. | 576.54M | -1.24% | 36,949 | - |
| 426 | MDXG | MiMedx Group, Inc. | 574.95M | -3.97% | 283,663 | 418.63M |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 574.78M | -2.08% | 586,815 | 296.15M |
| 428 | CTKB | Cytek Biosciences, Inc. | 571.41M | -3.79% | 111,744 | 201.49M |
| 429 | ESPR | Esperion Therapeutics, Inc. | 570.12M | 1.83% | 5,324,729 | 403.14M |
| 430 | UPB | Upstream Bio, Inc. | 568.14M | 0.19% | 309,149 | 2.85M |
| 431 | PRTA | Prothena Corporation plc | 560.40M | -1.61% | 81,909 | 9.68M |
| 432 | SIBN | SI-BONE, Inc. | 556.92M | -7.89% | 505,470 | 200.93M |
| 433 | ACRS | Aclaris Therapeutics, Inc. | 555.98M | -1.96% | 277,300 | 7.83M |
| 434 | PROK | ProKidney Corp. | 555.53M | -3.16% | 165,510 | 893.00K |
| 435 | ZVRA | Zevra Therapeutics, Inc. | 554.24M | -2.78% | 343,439 | 106.47M |
| 436 | BWAY | BrainsWay Ltd. | 553.94M | -2.38% | 41,447 | 52.23M |
| 437 | RIGL | Rigel Pharmaceuticals, Inc. | 544.03M | -3.47% | 327,704 | 294.28M |
| 438 | LYEL | Lyell Immunopharma, Inc. | 540.05M | -2.94% | 51,881 | 36.00K |
| 439 | KYTX | Kyverna Therapeutics, Inc. | 539.26M | -6.89% | 332,271 | - |
| 440 | TCMD | Tactile Systems Technology, Inc. | 537.02M | -1.48% | 49,204 | 329.52M |
| 441 | VALN | Valneva SE | 534.59M | - | 7,197 | 205.07M |
| 442 | EMBC | Embecta Corp. | 529.41M | 0.79% | 106,291 | 1.08B |
| 443 | ZURA | Zura Bio Limited | 523.74M | -1.43% | 174,719 | - |
| 444 | AVR | Anteris Technologies Global Corp. | 521.84M | -0.09% | 169,261 | 1.91M |
| 445 | STTK | Shattuck Labs, Inc. | 505.24M | -4.59% | 123,370 | 1.00M |
| 446 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 447 | LRMR | Larimar Therapeutics, Inc. | 502.79M | -4.91% | 612,223 | - |
| 448 | CATX | Perspective Therapeutics, Inc. | 501.88M | -1.89% | 147,813 | 884.00K |
| 449 | AGMB | AgomAb Therapeutics NV | 501.01M | 0.69% | 105,819 | - |
| 450 | AQST | Aquestive Therapeutics, Inc. | 498.55M | -2.04% | 446,831 | 44.55M |
| 451 | FULC | Fulcrum Therapeutics, Inc. | 497.50M | -5.56% | 384,007 | 80.00M |
| 452 | OFIX | Orthofix Medical Inc. | 496.18M | -0.48% | 41,463 | 822.31M |
| 453 | TRDA | Entrada Therapeutics, Inc. | 492.12M | -2.70% | 89,552 | 25.42M |
| 454 | FDMT | 4D Molecular Therapeutics, Inc. | 490.60M | -2.34% | 401,898 | 85.21M |
| 455 | IMMX | Immix Biopharma, Inc. | 487.18M | -5.74% | 195,922 | - |
| 456 | PHR | Phreesia, Inc. | 483.07M | -1.73% | 1,400,265 | 480.59M |
| 457 | KMDA | Kamada Ltd. | 481.97M | -0.24% | 15,025 | 180.46M |
| 458 | NPCE | NeuroPace, Inc. | 481.10M | -2.46% | 41,248 | 99.99M |
| 459 | CTNM | Contineum Therapeutics, Inc. | 480.89M | 0.39% | 75,878 | - |
| 460 | ENGN | enGene Holdings Inc. | 475.63M | -2.34% | 46,738 | - |
| 461 | IVVD | Invivyd, Inc. | 475.11M | -5.62% | 7,021,557 | 53.43M |
| 462 | ADCT | ADC Therapeutics SA | 472.61M | -1.06% | 259,660 | 81.36M |
| 463 | VSTM | Verastem, Inc. | 472.55M | -3.76% | 586,504 | 30.91M |
| 464 | EIKN | Eikon Therapeutics, Inc. | 467.22M | -4.22% | 290,728 | - |
| 465 | VREX | Varex Imaging Corporation | 462.79M | 0.73% | 68,907 | 854.40M |
| 466 | AVIR | Atea Pharmaceuticals, Inc. | 451.74M | -2.91% | 77,858 | - |
| 467 | ASMB | Assembly Biosciences, Inc. | 450.66M | -4.82% | 74,149 | 72.30M |
| 468 | LXEO | Lexeo Therapeutics, Inc. | 446.74M | -6.22% | 288,575 | - |
| 469 | RGNX | REGENXBIO Inc. | 446.49M | -3.46% | 202,340 | 170.44M |
| 470 | ABSI | Absci Corporation | 445.29M | -1.36% | 1,261,524 | 2.80M |
| 471 | VTVT | vTv Therapeutics Inc. | 443.02M | -4.29% | 30,519 | 17.00K |
| 472 | YDES | YD Bio Limited | 437.39M | 7.61% | 1,965 | 510.36K |
| 473 | AUNA | Auna S.A. | 435.94M | -1.51% | 68,991 | 1.30B |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.75M | -2.97% | 28,217 | - |
| 475 | AURA | Aura Biosciences, Inc. | 431.09M | -0.88% | 69,644 | - |
| 476 | XOMA | XOMA Royalty Corporation | 428.19M | -2.24% | 25,012 | 52.15M |
| 477 | CYH | Community Health Systems, Inc. | 422.34M | 0.16% | 461,536 | 12.49B |
| 478 | EBS | Emergent BioSolutions Inc. | 420.39M | -3.67% | 179,951 | 742.90M |
| 479 | ALT | Altimmune, Inc. | 420.24M | -4.44% | 701,797 | 41.00K |
| 480 | STRO | Sutro Biopharma, Inc. | 418.49M | -5.61% | 77,121 | 102.48M |
| 481 | VNDA | Vanda Pharmaceuticals Inc. | 417.89M | -3.55% | 396,931 | 216.11M |
| 482 | FLGT | Fulgent Genetics, Inc. | 415.65M | -4.06% | 252,181 | 322.67M |
| 483 | CGC | Canopy Growth Corporation | 413.19M | -3.67% | 4,695,064 | 203.04M |
| 484 | MYGN | Myriad Genetics, Inc. | 411.44M | -0.90% | 401,074 | 824.50M |
| 485 | ARMP | Armata Pharmaceuticals, Inc. | 409.74M | -2.99% | 9,057 | 4.90M |
| 486 | BBNX | Beta Bionics, Inc. | 407.65M | -4.62% | 613,577 | 100.25M |
| 487 | ZNTL | Zentalis Pharmaceuticals, Inc. | 407.14M | 29.86% | 33,224,789 | 26.87M |
| 488 | ANL | Adlai Nortye Ltd. | 407.01M | -8.08% | 188,454 | -1.35M |
| 489 | ENTA | Enanta Pharmaceuticals, Inc. | 406.56M | 0.43% | 106,034 | 66.98M |
| 490 | ANGO | AngioDynamics, Inc. | 405.57M | -3.57% | 80,367 | 313.73M |
| 491 | IPSC | Century Therapeutics, Inc. | 402.58M | -0.88% | 350,226 | 109.16M |
| 492 | KIDS | OrthoPediatrics Corp. | 400.92M | -0.50% | 18,543 | 236.35M |
| 493 | AUTL | Autolus Therapeutics plc | 400.55M | 2.38% | 916,527 | 75.39M |
| 494 | PACB | Pacific Biosciences of California, Inc. | 400.15M | -1.85% | 1,733,424 | 160.01M |
| 495 | REPL | Replimune Group, Inc. | 393.05M | -19.46% | 2,940,251 | - |
| 496 | CLYM | Climb Bio, Inc. | 390.98M | 1.68% | 430,900 | - |
| 497 | PBYI | Puma Biotechnology, Inc. | 389.71M | -1.79% | 87,482 | 228.37M |
| 498 | IRD | Opus Genetics, Inc. | 388.47M | -0.73% | 558,911 | 14.20M |
| 499 | PRTC | PureTech Health plc | 387.51M | 0.55% | 3,075 | 6.39M |
| 500 | BNTC | Benitec Biopharma Inc. | 384.34M | 1.91% | 57,022 | - |